Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib

R. A. Abdelrahman; K. H. Begna; A. Al-Kali; W. J. Hogan; M. R. Litzow; A. Tefferi

doi:10.1038/leu.2014.286

Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib

R. A. Abdelrahman, K. H. Begna, A. Al-Kali, W. J. Hogan, M. R. Litzow, A. Tefferi

Hematology

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	498-500
Number of pages	3
Journal	Leukemia
Volume	29
Issue number	2
DOIs	https://doi.org/10.1038/leu.2014.286
State	Published - Feb 7 2015

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/leu.2014.286

Cite this

@article{592561791e084188be23cfd7dbb29d4e,

title = "Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib",

author = "Abdelrahman, {R. A.} and Begna, {K. H.} and A. Al-Kali and Hogan, {W. J.} and Litzow, {M. R.} and A. Tefferi",

year = "2015",

month = feb,

day = "7",

doi = "10.1038/leu.2014.286",

language = "English (US)",

volume = "29",

pages = "498--500",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib

AU - Abdelrahman, R. A.

AU - Begna, K. H.

AU - Al-Kali, A.

AU - Hogan, W. J.

AU - Litzow, M. R.

AU - Tefferi, A.

PY - 2015/2/7

Y1 - 2015/2/7

UR - http://www.scopus.com/inward/record.url?scp=84922465797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922465797&partnerID=8YFLogxK

U2 - 10.1038/leu.2014.286

DO - 10.1038/leu.2014.286

M3 - Letter

C2 - 25252872

AN - SCOPUS:84922465797

SN - 0887-6924

VL - 29

SP - 498

EP - 500

JO - Leukemia

JF - Leukemia

IS - 2

ER -

Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this